Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus lenvatinib in previously treated patients with select solid tumors; results on efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer [Phase 2]
Phase 2 trial comparing MV-NIS versus investigator's choice chemotherapy in patients with ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwa…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating SOT101 in combination with pembrolizumab in selected advanced solid tumors was terminated; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies [Phase 1]
This clinical trial update notes the termination of a Phase 1 study of BDC-3042 as a single agent and in combination with cemiplimab in pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]
Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, spon…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Trial Evaluating TG4050 in Ovarian Carcinoma. [Phase 1]
Phase 1 trial evaluating TG4050 for ovarian cancer (including fallopian tube and peritoneal cancers) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin. [Phase 2]
This Phase 2, double-blind non-inferiority trial compares cilastatin to sodium thiosulfate for nephroprotection during debulking surgery wit…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer [Phase 1]
This clinical trial update confirms that MEN2501 is being evaluated in a first-in-human Phase 1 study for platinum-resistant ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports termination of NUV-868 as monotherapy and in combination with olaparib or enzalutamide in adults with adva…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 vaccine therapy trial for patients with Stage IIIC-IV ovarian ep…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of stereotactic body radiation therapy for recurrent primary ovarian or uterine cancer…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating quality of life after hyperthermic intraperitoneal chemotherapy in advanced ovarian, fallopian tube, and primary pe…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]
Open-label Phase 1 safety and tolerability study of INCB062079 in patients with advanced hepatocellular carcinoma and other malignancies; st…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2) [NA]
The VIRGO2 clinical trial, evaluating a value-based integrated recommendation software for guiding ovarian cancer treatment, has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completion of a real-world intensive monitoring study evaluating the use of olaparib in Chinese patients with ovarian or prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetics study of AMG 794 in Claudin-6–positive cancers, including non-small cell lung cancer and …
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. [NA]
Completed clinical trial evaluating vitamin B prophylaxis to reduce paclitaxel-induced neuropathy and assessing gabapentin use in diabetic o…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of NKT3447 in adults with advanced or metastatic solid tumors has been terminated. The study encompassed indications including…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UK
Real-world study of olaparib use and clinical outcomes in ovarian cancer patients in France, Italy, and the United Kingdom.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer [Phase 1]
Phase 1 study evaluating STRO-002 in combination with bevacizumab for epithelial ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating the combination of durvalumab and tremelimumab in participants with recurrent or treatment-refractory ovarian, fa…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Nudge to Gynecologic Oncology [NA]
A clinical trial update indicating the gynecologic oncology study is currently active but not recruiting, with conditions including ovarian …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation [NA]
A clinical trial sponsored by the University of Colorado, Denver is recruiting to study gonadal dysgenesis tissue cryopreservation for ferti…